- Home
- ARVN vs VRNT Comparison
ARVN vs VRNT Comparison
Compare ARVN & VRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- VRNT
- Stock Information
- Founded
- ARVN 2015
- VRNT 1994
- Country
- ARVN United States
- VRNT United States
- Employees
- ARVN N/A
- VRNT N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- VRNT EDP Services
- Sector
- ARVN Health Care
- VRNT Technology
- Exchange
- ARVN Nasdaq
- VRNT Nasdaq
- Market Cap
- ARVN 1.4B
- VRNT 1.5B
- IPO Year
- ARVN 2018
- VRNT N/A
- Fundamental
- Price
- ARVN $17.77
- VRNT $24.29
- Analyst Decision
- ARVN Strong Buy
- VRNT Buy
- Analyst Count
- ARVN 12
- VRNT 7
- Target Price
- ARVN $58.82
- VRNT $35.67
- AVG Volume (30 Days)
- ARVN 1.1M
- VRNT 456.2K
- Earning Date
- ARVN 02-11-2025
- VRNT 03-26-2025
- Dividend Yield
- ARVN N/A
- VRNT N/A
- EPS Growth
- ARVN N/A
- VRNT 2980.37
- EPS
- ARVN N/A
- VRNT 0.95
- Revenue
- ARVN $263,399,999.00
- VRNT $920,749,000.00
- Revenue This Year
- ARVN N/A
- VRNT $4.50
- Revenue Next Year
- ARVN $1.63
- VRNT $4.50
- P/E Ratio
- ARVN N/A
- VRNT $25.45
- Revenue Growth
- ARVN 235.54
- VRNT 4.45
- 52 Week Low
- ARVN $16.61
- VRNT $21.28
- 52 Week High
- ARVN $51.51
- VRNT $38.17
- Technical
- Relative Strength Index (RSI)
- ARVN 44.33
- VRNT 37.65
- Support Level
- ARVN $17.19
- VRNT $25.48
- Resistance Level
- ARVN $20.38
- VRNT $26.62
- Average True Range (ATR)
- ARVN 1.38
- VRNT 0.87
- MACD
- ARVN 0.08
- VRNT -0.08
- Stochastic Oscillator
- ARVN 30.77
- VRNT 12.46
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About VRNT Verint Systems Inc.
Verint Systems Inc with its subsidiaries helps brands provide Boundless Customer Engagement. The company's solutions help iconic brands close the gap created when it lacks the resources required to deliver experiences that fulfill customer expectations. Geographically, it derives a majority of its revenue from the United States.